Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Deferasirox

An iron chelator taken by mouth, approved in the United States in 2005: it removes the excess iron that builds up in patients receiving repeated transfusions, for example in beta-thalassaemia. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?Two of its molecules grip a single iron atom together; small and lipophilic, it can pull iron even from inside heart and liver cells.

DeferasiroxGo to the active ingredient →
DeferasiroxActive ingredientDeferasiroxCat. No. P-D031-001CAS 201530-41-8
Deferasirox-d4Isotopically labelledDeferasirox-d4Cat. No. P-D031-010CAS 1133425-75-8

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.